Haemonetics (HAE) Tops Q4 EPS by 1c, Offers Guidance
Get Alerts HAE Hot Sheet
Price: $119.65 -0.12%
EPS Growth %: +1.6%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
OPY, BNCC, ZVOI, More
EPS Growth %: +1.6%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $0.43, $0.01 better than the analyst estimate of $0.42. Revenue for the quarter came in at $233.6 million versus the consensus estimate of $227.12 million.
GUIDANCE:
Haemonetics sees FY2019 EPS of $2.00-$2.30, versus the consensus of $2.09.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Verra Mobility (VRRM) Tops Q3 EPS by 10c ; Offers Guidance
- Sensient Technologies (SXT) Tops Q3 EPS by 4c, Misses on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share